Literature DB >> 35007140

Antifungal Resistance Trends of Candida auris Clinical Isolates in New York and New Jersey from 2016 to 2020.

Shannon Kilburn1, Gabriel Innes2, Monica Quinn1, Karen Southwick3, Belinda Ostrowsky4, Jane A Greenko5, Emily Lutterloh1,6, Rebecca Greeley2, Reed Magleby2, Vishnu Chaturvedi1, Sudha Chaturvedi1,6.   

Abstract

About 55% of U.S. Candida auris clinical cases were reported from New York and New Jersey from 2016 through 2020. Nearly all New York-New Jersey clinical isolates (99.8%) were fluconazole resistant, and 50% were amphotericin B resistant. Echinocandin resistance increased from 0% to 4% and pan-resistance increased from 0 to <1% for New York C. auris clinical isolates but not for New Jersey, highlighting the regional differences.

Entities:  

Keywords:  Candida auris; antifungals; epidemiological cutoff; minimum inhibitory concentration

Mesh：

Substances：

Year:  2022        PMID： 35007140      PMCID： PMC8923207          DOI： 10.1128/aac.02242-21

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.938


  11 in total

1.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.

Authors:  Shawn R Lockhart; Kizee A Etienne; Snigdha Vallabhaneni; Joveria Farooqi; Anuradha Chowdhary; Nelesh P Govender; Arnaldo Lopes Colombo; Belinda Calvo; Christina A Cuomo; Christopher A Desjardins; Elizabeth L Berkow; Mariana Castanheira; Rindidzani E Magobo; Kauser Jabeen; Rana J Asghar; Jacques F Meis; Brendan Jackson; Tom Chiller; Anastasia P Litvintseva
Journal:  Clin Infect Dis       Date:  2016-10-20       Impact factor: 9.079

2.  In Vitro Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.

Authors:  Brittany O'Brien; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Laboratory Analysis of an Outbreak of Candida auris in New York from 2016 to 2018: Impact and Lessons Learned.

Authors:  YanChun Zhu; Brittany O'Brien; Lynn Leach; Alexandra Clarke; Marian Bates; Eleanor Adams; Belinda Ostrowsky; Monica Quinn; Elizabeth Dufort; Karen Southwick; Richard Erazo; Valerie B Haley; Coralie Bucher; Vishnu Chaturvedi; Ronald J Limberger; Debra Blog; Emily Lutterloh; Sudha Chaturvedi
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

4.  Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.

Authors:  Shallu Kathuria; Pradeep K Singh; Cheshta Sharma; Anupam Prakash; Aradhana Masih; Anil Kumar; Jacques F Meis; Anuradha Chowdhary
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

5.  First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia.

Authors:  Belinda Calvo; Analy S A Melo; Armindo Perozo-Mena; Martin Hernandez; Elaine Cristina Francisco; Ferry Hagen; Jacques F Meis; Arnaldo Lopes Colombo
Journal:  J Infect       Date:  2016-07-21       Impact factor: 6.072

Review 6.  The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.

Authors:  Ana Espinel-Ingroff; John Turnidge
Journal:  Rev Iberoam Micol       Date:  2016-06-11       Impact factor: 1.044

7.  Potential Fifth Clade of Candida auris, Iran, 2018.

Authors:  Nancy A Chow; Theun de Groot; Hamid Badali; Mahdi Abastabar; Tom M Chiller; Jacques F Meis
Journal:  Emerg Infect Dis       Date:  2019-09-17       Impact factor: 6.883

8.  Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria.

Authors:  Mark J Biagi; Nathan P Wiederhold; Connie Gibas; Brian L Wickes; Victoria Lozano; Susan C Bleasdale; Larry Danziger
Journal:  Open Forum Infect Dis       Date:  2019-06-01       Impact factor: 3.835

9.  Candida auris Isolates Resistant to Three Classes of Antifungal Medications - New York, 2019.

Authors:  Belinda Ostrowsky; Jane Greenko; Eleanor Adams; Monica Quinn; Brittany O'Brien; Vishnu Chaturvedi; Elizabeth Berkow; Snigdha Vallabhaneni; Kaitlin Forsberg; Sudha Chaturvedi; Emily Lutterloh; Debra Blog
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-01-10       Impact factor: 17.586

10.  Candida auris in Healthcare Facilities, New York, USA, 2013-2017.

Authors:  Eleanor Adams; Monica Quinn; Sharon Tsay; Eugenie Poirot; Sudha Chaturvedi; Karen Southwick; Jane Greenko; Rafael Fernandez; Alex Kallen; Snigdha Vallabhaneni; Valerie Haley; Brad Hutton; Debra Blog; Emily Lutterloh; Howard Zucker
Journal:  Emerg Infect Dis       Date:  2018-10       Impact factor: 6.883
View more
  6 in total

1.  Candida auris Pan-Drug-Resistant to Four Classes of Antifungal Agents.

Authors:  Samantha E Jacobs; Jonathan L Jacobs; Emily K Dennis; Sarah Taimur; Meenakshi Rana; Dhruv Patel; Melissa Gitman; Gopi Patel; Sarah Schaefer; Kishore Iyer; Jang Moon; Victoria Adams; Polina Lerner; Thomas J Walsh; YanChun Zhu; Mohammed Rokebul Anower; Mayuri M Vaidya; Sudha Chaturvedi; Vishnu Chaturvedi
Journal:  Antimicrob Agents Chemother       Date:  2022-06-30       Impact factor: 5.938

Review 2.  New Perspectives on Antimicrobial Agents: Isavuconazole.

Authors:  James S Lewis; Nathan P Wiederhold; Morgan Hakki; George R Thompson
Journal:  Antimicrob Agents Chemother       Date:  2022-08-15       Impact factor: 5.938

Review 3.  Clinical utility of antifungal susceptibility testing.

Authors:  Todd P McCarty; Paul M Luethy; John W Baddley; Peter G Pappas
Journal:  JAC Antimicrob Resist       Date:  2022-06-28

4.  Depletion of the Microbiota Has a Modest but Important Impact on the Fungal Burden of the Heart and Lungs during Early Systemic Candida auris Infection in Neutropenic Mice.

Authors:  Amber M Pichowicz; Steven R Torres; Fernando J Torres-Velez; Adina D Longyear; Navjot Singh; Erica Lasek-Nesselquist; Magdia De Jesus
Journal:  Microorganisms       Date:  2022-02-01

5.  Candida auris Bloodstream Infection Induces Upregulation of the PD-1/PD-L1 Immune Checkpoint Pathway in an Immunocompetent Mouse Model.

Authors:  Sebastian Wurster; Nathaniel D Albert; Dimitrios P Kontoyiannis
Journal:  mSphere       Date:  2022-02-28       Impact factor: 5.029

Review 6.  COVID-19-Associated Fungal Infections: An Urgent Need for Alternative Therapeutic Approach?

Authors:  Marianna Domán; Krisztián Bányai
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.